1 October 2012Patents

Indian Supreme Court to hear Novartis dispute over generic drugs

India’s highest court is set to hear a long-running dispute between Novartis and the country’s government, which has prevented the pharma company from patenting its cancer drug Gleevec.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk